Upon completion of this workshop, the healthcare professional will be able to:
- Review a recent meta-analysis of 21 studies demonstrating that thyroxine does not improve symptoms or quality of life in patients with SCH.
- Recognize that there is no clear evidence that symptoms are related to serum TSH levels.
- Critique the reasons as to why experts make a strong recommendation against the use of thyroid hormones, even in symptomatic patients with significant elevation of TSH.
- Discuss their logic in recommendations against thyroid hormone use due to the “potential harm, lack of benefit, being burdensome of some patients because of long-term daily medication requirements, the cost of follow up visits and testing, all of which stress the patient without any benefits.”
- Evaluate an opinion by an esteemed psychiatrist that hypothyroid patients, or patients with hypothyroid symptoms, should not be evaluated or treated by endocrinologists.
Neal Rouzier, MD
Enroll today with a Premium Membership for $495/year, for access to THIS course and:
- All 1 Hour Accredited Courses
- All upcoming Accredited Monthly Webinars
- All upcoming Journal Clubs AND Journal Club Library
- EBSCOhost – research articles for the BHRT Workshop Series and to support your own evidence based studies!